Primary |
Product Used For Unknown Indication |
26.1% |
Depression |
17.4% |
Parkinson's Disease |
17.4% |
Hiv Infection |
13.0% |
Generalised Anxiety Disorder |
8.7% |
Hypertension |
8.7% |
Arrhythmia |
4.3% |
Hypothyroidism |
4.3% |
|
Dyskinesia |
14.3% |
Haematospermia |
14.3% |
Hyponatraemia |
14.3% |
Myalgia |
14.3% |
Prothrombin Time Prolonged |
14.3% |
Sensory Loss |
14.3% |
Vomiting |
14.3% |
|
Secondary |
Product Used For Unknown Indication |
45.4% |
Schizophrenia |
10.7% |
Depression |
9.2% |
Psychotic Disorder |
8.0% |
Drug Use For Unknown Indication |
7.5% |
Hypertension |
4.5% |
Bipolar I Disorder |
4.2% |
Anxiety |
1.4% |
Hiv Infection |
1.3% |
Neck Pain |
1.3% |
Hypercholesterolaemia |
0.8% |
Insomnia |
0.8% |
Diabetes Mellitus |
0.7% |
Type 2 Diabetes Mellitus |
0.7% |
Thrombosis Prophylaxis |
0.6% |
Bipolar Disorder |
0.6% |
Dementia Alzheimer's Type |
0.6% |
Hypothyroidism |
0.6% |
Pain |
0.6% |
Prophylaxis |
0.6% |
|
Hepatitis Cholestatic |
9.2% |
Hyponatraemia |
7.8% |
Toxic Epidermal Necrolysis |
7.8% |
Vomiting |
7.8% |
Malaise |
7.1% |
Orthostatic Hypotension |
7.1% |
Thrombocytopenia |
7.1% |
Fall |
4.3% |
Premature Baby |
4.3% |
Rhabdomyolysis |
4.3% |
Somnolence |
4.3% |
Suicide Attempt |
4.3% |
Toxicity To Various Agents |
4.3% |
Wound |
4.3% |
Hepatitis |
3.5% |
Cataract |
2.8% |
Hypotension |
2.8% |
Pruritus |
2.8% |
Hepatic Fibrosis |
2.1% |
Inappropriate Antidiuretic Hormone Secretion |
2.1% |
|
Concomitant |
Product Used For Unknown Indication |
28.2% |
Drug Use For Unknown Indication |
17.2% |
Depression |
11.3% |
Hypertension |
6.6% |
Hepatitis C |
5.3% |
Hiv Infection |
5.0% |
Anxiety |
4.5% |
Pain |
3.3% |
Insomnia |
2.7% |
Schizophrenia |
2.2% |
Prophylaxis |
2.1% |
Bipolar Disorder |
1.8% |
Rheumatoid Arthritis |
1.5% |
Epilepsy |
1.4% |
Thrombosis Prophylaxis |
1.4% |
Breast Cancer |
1.3% |
Osteoporosis |
1.2% |
Diabetes Mellitus |
1.1% |
Acute Myeloid Leukaemia |
1.0% |
Atrial Fibrillation |
1.0% |
|
Renal Failure |
9.9% |
Renal Failure Acute |
9.9% |
Vomiting |
9.9% |
Thrombocytopenia |
8.9% |
Neutropenia |
5.4% |
Pulmonary Embolism |
5.0% |
Hepatocellular Injury |
4.5% |
Somnolence |
4.5% |
Weight Decreased |
4.5% |
Weight Increased |
4.5% |
Rhabdomyolysis |
4.0% |
Thrombophlebitis |
4.0% |
Toxic Skin Eruption |
4.0% |
Urticaria |
3.5% |
Lung Disorder |
3.0% |
Overdose |
3.0% |
Pyrexia |
3.0% |
Respiratory Distress |
3.0% |
Tremor |
3.0% |
Urinary Retention |
3.0% |
|
Interacting |
Drug Use For Unknown Indication |
26.3% |
Depression |
19.4% |
Atrial Fibrillation |
8.6% |
Arrhythmia |
5.1% |
Hypertension |
5.1% |
Asthma |
3.4% |
Musculoskeletal Pain |
3.4% |
Back Pain |
2.9% |
Insomnia |
2.9% |
Thrombosis Prophylaxis |
2.9% |
Type 2 Diabetes Mellitus |
2.9% |
Gastrooesophageal Reflux Disease |
2.3% |
Hiv Infection |
2.3% |
Osteoarthritis |
2.3% |
Product Used For Unknown Indication |
2.3% |
Alcohol Detoxification |
1.7% |
Hiatus Hernia |
1.7% |
Hypothyroidism |
1.7% |
Pain |
1.7% |
Angina Pectoris |
1.1% |
|
International Normalised Ratio Increased |
22.9% |
Drug Interaction |
11.4% |
Hypothermia |
8.6% |
Rectal Haemorrhage |
8.6% |
Ischaemic Stroke |
5.7% |
Pneumonia Aspiration |
5.7% |
Epilepsy |
2.9% |
Gastrointestinal Haemorrhage |
2.9% |
Hyponatraemia |
2.9% |
Inappropriate Antidiuretic Hormone Secretion |
2.9% |
Labelled Drug-drug Interaction Medication Error |
2.9% |
Neuropathy Peripheral |
2.9% |
Overdose |
2.9% |
Shock |
2.9% |
Subdural Haematoma |
2.9% |
Suicidal Ideation |
2.9% |
Urge Incontinence |
2.9% |
Urinary Retention |
2.9% |
Ventricular Extrasystoles |
2.9% |
|